Kimia Biosciences Stock Screener | Share Price & Fundamental Analysis
KIMIABL
Pharmaceuticals
Screen Kimia Biosciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹31.92
▼
-0.59 (-1.81%)
Market Cap
₹151.41 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
12.86
EPS (TTM)
₹2.03
Dividend Yield
-
Debt to Equity
7.46
52W High
₹80.78
52W Low
₹27.14
Operating Margin
14.00%
Profit Margin
6.30%
Revenue (TTM)
₹127.00
EBITDA
₹20.00
Net Income
₹8.00
Total Assets
₹111.00
Total Equity
₹10.00
Kimia Biosciences Share Price History - Stock Screener Chart
Screen KIMIABL historical share price movements with interactive charts. Analyze price trends and patterns.
Kimia Biosciences Company Profile - Fundamental Screener
Screen Kimia Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KIMIABL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE285U01025
Kimia Biosciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen KIMIABL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 111 | 100 | 121 | 110 | 107 | 86 | 65 | 58 | 12 | 4 |
| Current Assets | 75 | 61 | 83 | 73 | 72 | 61 | 48 | 43 | 2 | 1 |
| Fixed Assets | 33 | 32 | 34 | 35 | 28 | 18 | 16 | 13 | 7 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 111 | 100 | 121 | 110 | 107 | 86 | 65 | 58 | 12 | 4 |
| Current Liabilities | 19 | 30 | 40 | 33 | 37 | 34 | 29 | 25 | 9 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 10 | 0 | 6 | 15 | 18 | 13 | 6 | 2 | -5 | -4 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 2 | 2 | 7 | 7 |
| Reserves & Surplus | 5 | -4 | 1 | 10 | 14 | 9 | 2 | -2 | -12 | -11 |
Screen KIMIABL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 127 | 120 | 107 | 130 | 126 | 135 | 107 | 95 | 77 | 2 | 0 | 2 |
| Expenses | 108 | 99 | 105 | 134 | 124 | 124 | 102 | 88 | 74 | 2 | 4 | 4 |
| EBITDA | 20 | 22 | 1 | -4 | 2 | 11 | 5 | 7 | 3 | 0 | -3 | -1 |
| Operating Profit % | 14.00% | 17.00% | 0.00% | -4.00% | 1.00% | 6.00% | 4.00% | 6.00% | 3.00% | -67.00% | -1759.00% | -110.00% |
| Depreciation | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 0 | 0 | 0 |
| Interest | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 2 | 1 | 0 | 1 | 0 |
| Profit Before Tax | 12 | 14 | -7 | -12 | -5 | 6 | 1 | 4 | 2 | -1 | -4 | -2 |
| Tax | -1 | 4 | -2 | -3 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 8 | 10 | -5 | -9 | -4 | 5 | 1 | 4 | 2 | -1 | -4 | -2 |
| EPS | 1.70 | 2.03 | -1.12 | -1.98 | -0.78 | 1.08 | 0.33 | 2.64 | 1.14 | -1.26 | -5.49 | -2.31 |
Kimia Biosciences Cash Flow Screener - Liquidity Fundamentals
Screen KIMIABL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 21 | 15 | -7 | 8 | 6 | 0 | -3 | -7 | -1 | -6 |
| Investing Activities | -5 | -2 | -3 | -1 | -14 | -9 | -2 | -2 | -6 | 0 |
| Financing Activities | -17 | -13 | 10 | -8 | 8 | 9 | 4 | 10 | 7 | 6 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 |
Screen KIMIABL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.04% | 23.04% | 22.93% | 23.05% | 23.05% | 23.03% | 22.94% | 23.10% |
| Other Holding | 1.64% | 1.64% | 1.75% | 1.63% | 1.63% | 1.65% | 1.74% | 1.58% |
| Shareholder Count | 12,278 | 12,200 | 12,616 | 12,110 | 12,023 | 12,179 | 12,231 | 12,201 |
Kimia Biosciences Dividend Screener - Share Yield Analysis
Screen KIMIABL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Kimia Biosciences Index Membership - Market Screener Classification
Screen KIMIABL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Kimia Biosciences Market Events Screener - Corporate Actions
Screen KIMIABL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.53% | ||
| 2025-12-30 | 2025-12-30 | Annual General Meeting | NA | -9.62% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.25% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -7.15% |
| 2025-07-22 | 2025-07-22 | Extraordinary General Meeting | NA | 39.79% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 3.95% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -8.06% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.78% |
| 2019-01-04 | 2019-01-04 | Change Of Name | NA | 0.00% |
Kimia Biosciences Competitors Screener - Peer Comparison
Screen KIMIABL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,106 | 40.53 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,024 | 69.57 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,188 | 60.33 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 121,825 | 22.48 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 106,831 | 18.68 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 96,649 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 93,137 | 18.37 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 91,859 | 50.91 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,154 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,028 | 27.88 | 13,458 | 3.70% | 2,216 | 49.80 |
Kimia Biosciences Company Announcements - News Screener
Screen KIMIABL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-02 | Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-11-28 | Intimation Regarding Proposed Appointment Of Secretarial Auditor In Casual Vacancy Due To Non-Availability Of Previously Appointed Secretarial Auditor. | View |
| 2025-11-15 | Intimation Of Publication Of Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-14 | Results Financials For The Quarter And Half Year Ended On 30-09-2025. | View |
| 2025-11-14 | Board Meeting Outcome for Board Meeting Outcome As Per Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-11-10 | Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On September 30 2025. | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-10-01 | Intimation-Change Of Scrutiniser Due To Unavailability-AGM On 30Th September 2025. | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-06 | Intimation Of Book Closure/Record Date/E-Voting For The 32Nd Annual General Meeting | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | Intimation Of 32Nd Annual General Meeting Of The Company Proposed To Be Held On September 30 2025 At 4:00 P.M. Through Video Conferencing/Other Audio Visual Means. | View |
| 2025-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-29 | Board Meeting Outcome for Outcome Of Board Meeting Dated 29.08.2025 | View |
| 2025-08-26 | Board Meeting Intimation for Board Meeting To Be Held On Friday August 29 2025 | View |